Journal of Geriatric Psychiatry and Neurology · 1999 · 36 citations · 18 references
MedicinePsychiatryPsychologyGeriatric PsychiatryNeuropsychiatryPsychiatric AssessmentCognitive ImpairmentCognitive SymptomsMental IllnessNeurocognitive DisordersPsychotic DisordersSchizophrenia Spectrum DisordersAbnormal Involuntary Movement ScaleCognitive Impairment AssociationsCognitive Impairment In SchizophreniaNegative Syndrome ScaleNeurocognitive DeficitsNeurocognitive FunctioningNeurocognitive ProfilePositive Syndrome Scale
We evaluated psychiatric symptoms and neurocognitive functioning among 25 institutionalized and 25 outpatient DSM-IV-diagnosed schizophrenia patients, as well as 25 middle-aged and elderly normal comparison subjects. All subjects were assessed with the Positive and Negative Syndrome Scale, Hamilton Rating Scale for Depression, modified Simpson-Angus Extrapyramidal Symptom Scale, the Abnormal Involuntary Movement Scale, and the Mattis Dementia Rating Scale (DRS). The two patient groups had similar levels of depressive symptoms, but the institutionalized patients had more severe positive and negative symptoms and were on higher doses of neuroleptic medication. The institutionalized patients had significantly more cognitive impairment on the DRS than outpatients and normal comparison subjects, particularly on the subscales of initiation/perseveration, conceptualization, and memory. Results are discussed in terms of the possible neuropathology associated with cognitive impairment in chronic schizophrenia.
18
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
G. M. Simpson, M. B., GH. B. et al. · Acta Psychiatrica Scandinavica · 1970 · 3.3K citations
Medicine, Pharmacology, Psychiatry +10
Michio Yamada, S Mitsuno, Shoko Kato et al. · PubMed · 1997 · 687 citations
Neuropsychological Deficits in Schizophrenics
Robert K. Heaton · Archives of General Psychiatry · 1994 · 383 citations
Medicine, Psychiatry, Memory +16